1 Min Read
Oct 31 (Reuters) - Perkinelmer Inc
* Phase II clinical trial data establishes effectiveness of using a child’s own cord blood to treat cerebral palsy Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.